Citigroup’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119K Sell
15,589
-4,605
-23% -$35.2K ﹤0.01% 4215
2025
Q4
$196K Buy
20,194
+13,067
+183% +$111K ﹤0.01% 4013
2025
Q3
$29.9K Sell
7,127
-32,308
-82% -$206K ﹤0.01% 4663
2025
Q2
$366K Sell
39,435
-76,034
-66% -$663K ﹤0.01% 3793
2025
Q1
$1.13M Buy
115,469
+30,090
+35% +$372K ﹤0.01% 3161
2024
Q4
$1.03M Buy
85,379
+39,657
+87% +$482K ﹤0.01% 3343
2024
Q3
$501K Buy
45,722
+25,859
+130% +$263K ﹤0.01% 3723
2024
Q2
$179K Sell
19,863
-522,626
-96% -$3.64M ﹤0.01% 3951
2024
Q1
$4.43M Buy
542,489
+359,228
+196% +$2.95M ﹤0.01% 1797
2023
Q4
$1.54M Buy
183,261
+103,734
+130% +$1.2M ﹤0.01% 2463
2023
Q3
$1.36M Buy
79,527
+26,059
+49% +$512K ﹤0.01% 2282
2023
Q2
$1.24M Sell
53,468
-120,508
-69% -$2.35M ﹤0.01% 2663
2023
Q1
$3.07M Buy
173,976
+139,797
+409% +$3.32M ﹤0.01% 1750
2022
Q4
$930K Sell
34,179
-35,855
-51% -$745K ﹤0.01% 2670
2022
Q3
$1.21M Buy
70,034
+9,927
+17% +$189K ﹤0.01% 2569
2022
Q2
$1.05M Buy
60,107
+42,049
+233% +$691K ﹤0.01% 2609
2022
Q1
$307K Sell
18,058
-42,182
-70% -$796K ﹤0.01% 3832
2021
Q4
$1.63M Buy
60,240
+14,492
+32% +$433K ﹤0.01% 2785
2021
Q3
$1.36M Sell
45,748
-61,298
-57% -$1.99M ﹤0.01% 2851
2021
Q2
$4.11M Sell
107,046
-14,596
-12% -$499K ﹤0.01% 2064
2021
Q1
$3.71M Buy
121,642
+115,184
+1,784% +$4.31M ﹤0.01% 2022
2020
Q4
$246K Buy
6,458
+5,243
+432% +$218K ﹤0.01% 4836
2020
Q3
$28K Sell
1,215
-3,156
-72% -$71.9K ﹤0.01% 5963
2020
Q2
$109K Sell
4,371
-21,203
-83% -$375K ﹤0.01% 5510
2020
Q1
$255K Buy
25,574
+22,864
+844% +$341K ﹤0.01% 4523
2019
Q4
$39K Buy
2,710
+1,203
+80% +$17.3K ﹤0.01% 6510
2019
Q3
$21K Sell
1,507
-2,577
-63% -$31.6K ﹤0.01% 6709
2019
Q2
$59K Buy
4,084
+376
+10% +$5.44K ﹤0.01% 6322
2019
Q1
$56K Buy
3,708
+2,132
+135% +$26.6K ﹤0.01% 6247
2018
Q4
$15K Sell
1,576
-614
-28% -$8.3K ﹤0.01% 7010
2018
Q3
$36K Buy
+2,190
New +$38.4K ﹤0.01% 6779

Other funds holding REPL

Citigroup's REPL Position: Q1 2026 in Review

Citigroup reduced its Replimune Group (REPL) stake by 23% in Q1 2026, selling an estimated $35.2K and leaving 15,589 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #4215.

Citigroup first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.43M in Q1 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Citigroup held 15,589 shares of Replimune Group worth $119K as of Q1 2026.
  • Citigroup sold 4,605 Replimune Group shares in Q1 2026, an estimated $35.2K.
  • Replimune Group made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4215 holding.
  • Citigroup first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Citigroup's Replimune Group position peaked at $4.43M in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.